According to in vitro research, Nrf2 overexpression can raise the expression of a number of intracellular redox-balancing proteins, phase II detoxifying enzymes, and transporters, which can provide cancer cells a growth advantage and result in chemotherapy resistance. Here, NFE2L2 is linked to cancer.